[SS09] Young Pharmaceutical Scientists Pioneer Future Oligonucleotide Therapeutics

2:32 PM - 2:43 PM JST(5:32 AM - 5:43 AM UTC)

[SS09-6] Establishment of a platform for the development of gapmer-type antisense oligonucleotides and the application of drug discovery for the intractable diseases

○Yuuya Kasahara^1,2 (1. NIBIOHN, 2. Grad. Sch. Pharm. Sci., Osaka Univ.)